Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02643238 · ClinicalTrials.gov registry record · NA

Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation

A NA study, sponsored by Akron Children's Hospital.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT02643238 is a NA study that has completed, run by Akron Children's Hospital. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02643238, a NA study, has completed, sponsored by Akron Children's Hospital.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the use of an artificial vision system called Brainport system in blind patients To investigate visual, and oculomotor (eye motion) mechanisms involved in the use of the Brainport system.

Interventions

  • DEVICE BrainPort

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2011-10
Est. Completion 2022-05
Phase NA

Sponsor

Akron Children's Hospital

27 total trials

What the Registry Record Tells You About NCT02643238

The ClinicalTrials.gov registry entry for NCT02643238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BrainPort is the first listed.

NCT02643238 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02643238 about?

NCT02643238 is a clinical study titled "Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation". The purpose of this study is to evaluate the use of an artificial vision system called Brainport system in blind patients To investigate visual, and oculomotor (eye motion) mechanisms involved in the use of the Brainport system.

What is the current status of trial NCT02643238?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2011-10. Estimated completion is 2022-05.

What interventions are being tested in trial NCT02643238?

The interventions under investigation include: BrainPort (DEVICE).

Who is sponsoring clinical trial NCT02643238?

This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.